Pancreatic Cancer Trial, Recruiting NCT07651358 Sponsor: OHSU Knight Cancer Institute Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07651358
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older at the time of enrollment
  • People who have been diagnosed with stage I, II, or III pancreatic cancer
  • People who are scheduled to receive chemotherapy before surgery (called neoadjuvant chemotherapy) at Oregon Health & Science University (OHSU)
  • People who are willing to follow the study's requirements and procedures

Who may not be able to join:

  • People who have cognitive difficulties that would make it hard to answer survey questions, take part in the program, or give informed consent
  • People who have a medical condition, movement disorder, neurological disorder, or take a medication that would make even light-intensity exercise unsafe for them
  • People who are not fluent in English, as the surveys, the online program, and the consent process are all conducted in English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
OHSU Knight Cancer Institute
Registry
ClinicalTrials.gov
Start date
15 April 2026
Est. completion
31 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accrual (Acceptability); Study retention (Acceptability); Listening session; Exit survey; Study intervention adherence (Feasibility); Web portal visit frequency (Feasibility); Web portal aggregate activity (Feasibility)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov